Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational - Methylation Status as Predictor of Response to Neoadjuvant Chemotherapy in Osteosarcoma

NCT01374672 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01374672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01374672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational - Methylation Status as Predictor of Response to Neoadjuvant Chemotherapy in Osteosarcoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
September 30, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized osteosarcoma, metastatic osteosarcoma, osteoblastic osteosarcoma, recurrent osteosarcoma